Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus

Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus

This case series examines the efficacy of anifrolumab as a therapeutic option for patients with lupus erythematosus.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of dermatology (1960) 2023-05, Vol.159 (5), p.560-563
Hauptverfasser: Shaw, Katharina, Sanchez-Melendez, Stephanie, Taylor, Dustin, Barker, Julia, LaChance, Avery, Shahriari, Neda, Vleugels, Ruth Ann
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal, Humanized - therapeutic use
Clinical outcomes
Comments
Humans
Letters
Lupus
Lupus Erythematosus, Discoid - diagnosis
Lupus Erythematosus, Discoid - drug therapy
Lupus Erythematosus, Systemic
Medical treatment
Monoclonal antibodies
Online First
Research Letter
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This case series examines the efficacy of anifrolumab as a therapeutic option for patients with lupus erythematosus.
ISSN:2168-6068
2168-6084
DOI:10.1001/jamadermatol.2023.0175